| Dr Robert F Weiss, DPM | |
|
800 Post Rd, Darien, CT 06820-4622 | |
| (203) 656-1696 | |
| (203) 656-1742 |
| Full Name | Dr Robert F Weiss |
|---|---|
| Gender | Male |
| Speciality | Podiatrist |
| Location | 800 Post Rd, Darien, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033117866 | NPI | - | NPPES |
| 300091359 | Other | CT | TAX ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 000219 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert F Weiss, DPM 800 Post Rd, Darien, CT 06820-4622 Ph: (203) 656-1696 | Dr Robert F Weiss, DPM 800 Post Rd, Darien, CT 06820-4622 Ph: (203) 656-1696 |
News Archive
While authorities in Greece anxiously await test results on eight dead birds found in the northeastern Evros River delta, in another main migratory route, Croatia had also started testing dead birds found by citizens.
A self-sustaining energy harvesting device that requires no physical exercise can accumulate 300 mJ of energy in a 10-hour sleep period.
Does a new medicine or diagnostic test work? Is it safe? Should the government approve it and insurers pay for it? The answers are not as straightforward as they may seem - and the reasons are the subject of a new book by Karen J. Maschke, a research scholar at The Hastings Center, and Michael K. Gusmano, a Hastings Center research scholar and an associate professor of health policy at Rutgers University School of Public Health.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares ("ADSs"), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of 1,800,000 additional ADSs to cover over-allotments.
BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called Accurins, announced today the presentation of late-breaker clinical data for BIND-014, the lead drug candidate within a new class of targeted therapeutics that are programmed to concentrate at tumors, at the American Association for Cancer Research (AACR) 2012 Annual Meeting.
› Verified 3 days ago
Josephine Velazquez, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 20 Old Kings Hwy S, Darien, CT 06820 Phone: 203-655-6299 Fax: 203-656-2607 | |
The Foot & Ankle Institute Of Darien Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 800 Post Rd, Darien, CT 06820 Phone: 203-656-1696 Fax: 203-656-1742 | |
Dr. Scott H Weiss, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 800 Post Rd, Suite 302, Darien, CT 06820 Phone: 203-656-1696 Fax: 203-656-1742 | |
Dr. Matthew Juriga, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 800 Post Rd, Suite 302, Darien, CT 06820 Phone: 203-656-1696 Fax: 203-656-1742 | |
Dr. Rachel Hannah Albright, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 800 Post Rd Ste 302, Darien, CT 06820 Phone: 203-656-1696 Fax: 203-656-1742 |